| Hayley Hoffman, CNM | |
|
22 S Greene St, Baltimore, MD 21201-1544 | |
| (410) 328-5964 | |
| Not Available |
| Full Name | Hayley Hoffman |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 22 S Greene St, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376945410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (Maryland) | Primary |
| Entity Name | University Of Maryland Obstetrical And Gynecological Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144252990 PECOS PAC ID: 8820083363 Enrollment ID: O20040415000691 |
News Archive
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
Writing in the latest edition of Australian Prescriber, Associate Professor Helen Reddel, research leader at the Woolcock Institute of Medical Research says many people are prescribed higher doses than necessary. Most people do not use their inhalers correctly, leading to poor clinical outcomes and wasted medicines.
A new report from the University of New Hampshire's Crimes against Children Research Center, using data collected by the U.S. Department of Health and Human Services, showed a marked increase in the share of child maltreatment cases resulting in fatalities as well as a decline in cases of physical abuse and neglect in 2019.
Results of a US study show that hemostatic screening tests are important in the evaluation of young women with heavy menstrual bleeding.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in Hematology and Oncology, and Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs, today jointly announced the results from their Phase 1 combination trial of belinostat (Beleodaq) with the CHOP (Cyclophosphamide, Hydroxyl-doxorubicin; Vincristine, and Prednisone) chemotherapy regimen as first-line treatment for newly diagnosed peripheral T-cell lymphoma (PTCL).
› Verified 7 days ago
| Entity Name | Chase Brexton Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588606305 PECOS PAC ID: 5395644835 Enrollment ID: O20040512000520 |
News Archive
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
Writing in the latest edition of Australian Prescriber, Associate Professor Helen Reddel, research leader at the Woolcock Institute of Medical Research says many people are prescribed higher doses than necessary. Most people do not use their inhalers correctly, leading to poor clinical outcomes and wasted medicines.
A new report from the University of New Hampshire's Crimes against Children Research Center, using data collected by the U.S. Department of Health and Human Services, showed a marked increase in the share of child maltreatment cases resulting in fatalities as well as a decline in cases of physical abuse and neglect in 2019.
Results of a US study show that hemostatic screening tests are important in the evaluation of young women with heavy menstrual bleeding.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in Hematology and Oncology, and Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs, today jointly announced the results from their Phase 1 combination trial of belinostat (Beleodaq) with the CHOP (Cyclophosphamide, Hydroxyl-doxorubicin; Vincristine, and Prednisone) chemotherapy regimen as first-line treatment for newly diagnosed peripheral T-cell lymphoma (PTCL).
› Verified 7 days ago
| Entity Name | Seton Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144409194 PECOS PAC ID: 7416037924 Enrollment ID: O20080122000384 |
News Archive
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
Writing in the latest edition of Australian Prescriber, Associate Professor Helen Reddel, research leader at the Woolcock Institute of Medical Research says many people are prescribed higher doses than necessary. Most people do not use their inhalers correctly, leading to poor clinical outcomes and wasted medicines.
A new report from the University of New Hampshire's Crimes against Children Research Center, using data collected by the U.S. Department of Health and Human Services, showed a marked increase in the share of child maltreatment cases resulting in fatalities as well as a decline in cases of physical abuse and neglect in 2019.
Results of a US study show that hemostatic screening tests are important in the evaluation of young women with heavy menstrual bleeding.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in Hematology and Oncology, and Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs, today jointly announced the results from their Phase 1 combination trial of belinostat (Beleodaq) with the CHOP (Cyclophosphamide, Hydroxyl-doxorubicin; Vincristine, and Prednisone) chemotherapy regimen as first-line treatment for newly diagnosed peripheral T-cell lymphoma (PTCL).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hayley Hoffman, CNM 11 S Paca St, Baltimore, MD 21201-1791 Ph: (410) 328-3589 | Hayley Hoffman, CNM 22 S Greene St, Baltimore, MD 21201-1544 Ph: (410) 328-5964 |
News Archive
The rise of continuous blood glucose monitor and insulin pump technologies has lessened the intricate task of monitoring and regulating blood glucose levels for people with diabetes, but improvements to these devices could still significantly improve lives.
Writing in the latest edition of Australian Prescriber, Associate Professor Helen Reddel, research leader at the Woolcock Institute of Medical Research says many people are prescribed higher doses than necessary. Most people do not use their inhalers correctly, leading to poor clinical outcomes and wasted medicines.
A new report from the University of New Hampshire's Crimes against Children Research Center, using data collected by the U.S. Department of Health and Human Services, showed a marked increase in the share of child maltreatment cases resulting in fatalities as well as a decline in cases of physical abuse and neglect in 2019.
Results of a US study show that hemostatic screening tests are important in the evaluation of young women with heavy menstrual bleeding.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in Hematology and Oncology, and Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs, today jointly announced the results from their Phase 1 combination trial of belinostat (Beleodaq) with the CHOP (Cyclophosphamide, Hydroxyl-doxorubicin; Vincristine, and Prednisone) chemotherapy regimen as first-line treatment for newly diagnosed peripheral T-cell lymphoma (PTCL).
› Verified 7 days ago
Ms. Sharon Maree Elmes-curtis, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 6701 N Charles St, Dept Of Labor And Delivery, Baltimore, MD 21204 Phone: 443-849-2577 | |
Archana Sharma, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 301 Saint Paul Pl, Tower # 306, Baltimore, MD 21202 Phone: 410-385-5151 Fax: 410-962-8763 | |
Sarah Proett, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 900 S Caton Ave, Mailbox 081, Baltimore, MD 21229 Phone: 443-703-3200 Fax: 443-703-3201 | |
Ms. Lauren Kelly Rosales, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1701 Barclay St, Baltimore, MD 21202 Phone: 630-809-6115 | |
Julia Bluestone, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 330 N Howard St, Baltimore, MD 21201 Phone: 410-576-2130 | |
Anne B Woods, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 9000 Franklin Square Dr, Women's Pavilion, Baltimore, MD 21237 Phone: 443-777-8005 | |
Mrs. Kara Hickey, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 330 N Howard St, Suite 200, Baltimore, MD 21201 Phone: 301-332-4968 |